Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • ECO
    --Site Admin--
    • Oct 2007
    • 1360

    Heliscope instrument pricing announced

    Helicos™ Genetic Analysis System $1,350,000 USD The Helicos™ Genetic Analysis System is the first True Single Molecule Sequencing™ (tSMS) platform available to leading genomics researchers. The HeliScope™, the world’s first DNA Microscope™, provides superior throughput to open new research avenues, increases site productivity and dramatically reduces the time for completing complex genomic experiments. Novel reagent packaging and intuitive software provide for easy operation, automated tracking of consumables, and overall management of the System. The HeliScope™ Analysis Engine provides extensive computing power for near real time image analysis and to eliminate waiting for data. It comes standard with 28 terabytes of data storage. A web application supports remote monitoring and administration of the System. Includes: HeliScope , Sample Loader, Analysis Engine, System Software, Installation, Start-Up Kit and One Year Warranty.

    Helicos tSMS Genomic Signature Sequencing (GSS)™ Reagent Kit – K-GSSA $18,000 USD The tSMS™ reagent kit for GSS™ contains the reagents and consumables necessary for performing Genomic Signature Sequencing™ on the Helicos Genetic Analysis System. Includes: tSMS Reagents, (2) 25 Channel Application-specific Flow Cells, Sample Loading Solutions, System Maintenance Kit, and GSS Specific Reagents.

    Helicos True Single Molecule Sequencing (tSMS)™ Multi-Pass Reagent Kit – K-MPSA
    $18,000 USD The tSMS™ reagent kit for sequencing contains the reagents and consumables necessary for performing high accuracy sequencing applications on the Helicos Genetic Analysis System. Includes: tSMS Reagents (for two pass sequencing), (2) 25 Channel Application-specific Flow Cells, Sample Loading Solutions, System Maintenance Kit and Multi-Pass Sequencing Specific Reagents.
    Just released on Helicos' website. The instrument is significantly cheaper than the previously discussed number of $2 Million, but still more expensive than the competition.

    I hope to put up a reagent/true-cost-of-ownership analysis soon.

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
210 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
78 views
0 reactions
Last Post SEQadmin2  
Working...